{"id":567746,"date":"2026-08-13T11:36:10","date_gmt":"2026-08-13T11:36:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/567746\/"},"modified":"2026-08-13T11:36:10","modified_gmt":"2026-08-13T11:36:10","slug":"androlabs-appoints-effrx-as-swiss-commercial-partner-for-testosterone-therapy-testavan","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/567746\/","title":{"rendered":"Androlabs appoints EffRx as Swiss commercial partner for testosterone therapy Testavan"},"content":{"rendered":"

The men’s health firm Androlabs has tapped EffRx Pharmaceuticals to be its\u00a0commercial partner in Switzerland for Testavan, a testosterone replacement therapy indicated for hypogonadism in adult men.\u00a0<\/p>\n

The therapy is already commercially available in Switzerland. Under the agreement, EffRx will lead the commercialisation and distribution of Testavan in the country.<\/p>\n

Low testosterone affects roughly 10-40% of men globally<\/a>; however, it remains underdiagnosed, with symptoms often attributed to ageing or other health conditions, potentially delaying appropriate medical assessment and treatment.<\/p>\n

As Switzerland’s population continues to age, the prevalence of age-related health conditions affecting men is expected to increase, reinforcing the importance of timely diagnosis and access to appropriate treatment options.\u00a0<\/p>\n

Nicolas Vennin, co-founder of Androlabs, said: \u201cWe look forward to working with EffRx to expand access to Testavan in Switzerland and offer greater choice to patients and healthcare professionals.”<\/p>\n

This partnership represents an important step forward in our shared commitment to advancing men\u2019s health in the country.<\/p>\n

Victor Papavasileiou, EVP Corporate Development at EffRx Pharmaceuticals, added: \u201cWe are pleased to partner with Androlabs to commercialise and distribute Testavan in Switzerland.”<\/p>\n

Testavan is an important addition to our portfolio and this agreement demonstrates our commitment to bringing patient-focused treatments to the Swiss market.<\/p>\n

The news comes two weeks after Androlabs announced a similar partnership with Laboratoires Majorelle to market Testavan in France.<\/p>\n

\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"The men’s health firm Androlabs has tapped EffRx Pharmaceuticals to be its\u00a0commercial partner in Switzerland for Testavan, a…\n","protected":false},"author":2,"featured_media":567747,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[134,111,139,69],"class_list":["post-567746","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/567746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=567746"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/567746\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/567747"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=567746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=567746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=567746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}